title: Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL.
authors.forename: Kim
authors.initials: K
authors.lastname: De Keersmaecker
authors.forename: Lucienne
authors.initials: L
authors.lastname: Michaux
authors.forename: André
authors.initials: A
authors.lastname: Bosly
authors.forename: Carlos
authors.initials: C
authors.lastname: Graux
authors.forename: Julio Finalet
authors.initials: JF
authors.lastname: Ferreiro
authors.forename: Peter
authors.initials: P
authors.lastname: Vandenberghe
authors.forename: Jan
authors.initials: J
authors.lastname: Cools
authors.forename: Iwona
authors.initials: I
authors.lastname: Wlodarska
mesh_terms: D000081242:B-Cell Lymphoma 3 Protein; D018450:Disease Progression; D015321:Gene Rearrangement / Q000235:genetics*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D051881:Receptor, Notch1 / Q000235:genetics*; D012008:Recurrence; D014157:Transcription Factors / Q000235:genetics*
chemical_list: D000081242:B-Cell Lymphoma 3 Protein; C000631344:BCL3 protein, human; C497761:NOTCH1 protein, human; D011518:Proto-Oncogene Proteins; D051881:Receptor, Notch1; D014157:Transcription Factors